Characterization of calcium-independent forms of protein kinase C-beta in phorbol ester-treated rabbit platelets

J Biol Chem. 1991 May 15;266(14):8696-705.

Abstract

The subcellular distribution, size, and activation state of protein kinase C (PKC) were studied after short term exposure of rabbit platelets to a saturating dose of 12-O-tetradecanoylphorbol 13-acetate (TPA). Cytosolic and Nonidet P-40-solubilized particulate extracts prepared from TPA-treated platelets were subjected to analytical column chromatography on Mono Q, hydroxylapatite, and Superose 6/12. PKC activity was assayed according to the ability of the enzyme to phosphorylate (i) histone H1 in the presence of the activators calcium, diacylglycerol, and phosphatidylserine; (ii) histone H1 after proteolytic activation of PKC with trypsin; and (iii) protamine in the absence of calcium and lipid. Within 1 min of TPA treatment of platelets, greater than 95% of the PKC activity was particulate associated, as assessed by all three methods. The particulate PKC activity from 1-min TPA-treated cells eluted from Mono Q with approximately 0.35 M NaCl (peak I), and it was highly dependent upon Ca2+ and lipid for optimal histone H1 phosphorylation. With longer exposure times of platelets to TPA, the disappearance of the Mono Q peak I form of PKC was correlated with the production of new PKC species that were released from Mono Q with approximately 0.4 M NaCl (peak II), approximately 0.5 M NaCl (peak III), and approximately 0.6 M NaCl (peak IV). These last forms of PKC were still lipid activated but exhibited little Ca2+ dependence. The Mono Q peak III form displayed a particularly high level of histone H1 phosphorylating activity in the absence of lipid and Ca2+. All of these forms behaved as approximately 65-kDa proteins on Superose 6/12, but on sodium dodecyl sulfate-polyacrylamide gels, Western blotting with anti-PKC-beta antibodies revealed immunoreactive polypeptides of approximately 79 kDa (Mono Q peaks I, II, and IV) and approximately 100-kDa (Mono Q peak III). Hydroxylapatite column chromatography permitted partial resolution of the Mono Q peaks I and II forms, which were eluted within a concentration range of potassium phosphate (100-150 mM) which was typical of the beta isozyme of PKC. Treatment of the Mono Q peak III and IV PKC forms with alkaline phosphatase resulted in the production of the peak I form, which implicated protein phosphorylation in the interconversion of the various PKC forms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase / pharmacology
  • Amino Acid Sequence
  • Animals
  • Blood Platelets / enzymology*
  • Blotting, Western
  • Calcium / blood
  • Cell Compartmentation / drug effects
  • Enzyme Activation / drug effects
  • In Vitro Techniques
  • Leupeptins / pharmacology
  • Molecular Sequence Data
  • Molecular Weight
  • Peptides / chemistry
  • Phosphorylation
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / blood*
  • Protein Kinase C / immunology
  • Rabbits
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Leupeptins
  • Peptides
  • Protein Kinase C
  • Alkaline Phosphatase
  • leupeptin
  • Tetradecanoylphorbol Acetate
  • Calcium